HAEMOPHILIA AND BLOOD PRODUCTS

Early day motion 417, tabled 18 December 2002 by Michael Connarty (Labour). Signed by 119 members.

That this House notes the recent report highlighting that the United Kingdom has the lowest provision of recombinant product for the use of people with haemophilia in the developed world; notes the recent medical concerns suggesting vCJD might be carried in infected blood products, and calls on the Government to make this synthetic alternative to blood products available to all people with haemophilia without further delay and thereby remove from patients with haemophilia the fear that the blood products that they rely on daily for treatment may pass on this terrible disease.

Signatures by party: Labour 84, Liberal Democrat 14, Conservative 8, Labour/Co-operative 8, UUP 3, Plaid Cymru 1, Social Democratic and Labour Party 1.